叶状肿瘤中原位/浸润性癌的高共存率:10年回顾性和回顾研究。

Öykü Dila Gemci, Serdar Altınay, Rümeysa İlbar Tartar, Sina Ferahman
{"title":"叶状肿瘤中原位/浸润性癌的高共存率:10年回顾性和回顾研究。","authors":"Öykü Dila Gemci,&nbsp;Serdar Altınay,&nbsp;Rümeysa İlbar Tartar,&nbsp;Sina Ferahman","doi":"10.4274/ejbh.galenos.2022.2022-6-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Phyllodes tumors (PTs) are a rare group of breast tumors. Most malignant transformations are <i>in situ</i> carcinomas that are extremely rare and are limited to individual cases in the literature. The presence of <i>in situ</i>/invasive carcinomas is important as this may alter clinical judgment and management. In this study, we aimed to determine the association of <i>in situ</i>/invasive carcinomas among PTs.</p><p><strong>Materials and methods: </strong>This retrospectively designed study included cases diagnosed with PTs between 2011 and 2020 in the pathology department of a tertiary level hospital. Tumors were grouped into benign, borderline and malignant, according to stromal overgrowth, stromal atypia, stromal cellularity and mitotic activity. In addition, age, location, type of operation, tumor diameter, and surgical margin information were recorded. <i>in situ</i> and/or invasive carcinoma foci accompanying the PTs were assessed.</p><p><strong>Results: </strong>A total of 29 patients diagnosed with PTs were identified, among whom 14 (48.2%) had benign PTs, 10 (34.4%) had borderline PTs, and 5 (17.2%) had malignant PTs. Of the patients with PTs, 3 (10.3%) had coexistent invasive carcinoma and 1 (3.4%) had carcinoma <i>in situ</i>. In this cohort the incidence of coexistence of PT and carcinoma was 4/29 (13.7%), which is much higher than previously reported (1.1% and 6%). The incidence of carcinoma was 2/5 (40%) in malignant PT patients and 2/10 (20%) in borderline PT patients. The coexistence of malignant PTs and carcinoma was significantly higher than those of benign and borderline PTs (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>The multidisciplinary team dealing with breast diseases has a great responsibility in both diagnosis and treatment. We anticipate that these rates will increase with an increase in the awareness and importance of this coexistence of carcinoma and PTs.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"18 4","pages":"343-352"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521284/pdf/ejbh-18-343.pdf","citationCount":"0","resultStr":"{\"title\":\"Unexpectedly High Coexistence Rate of <i>In Situ</i>/Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study.\",\"authors\":\"Öykü Dila Gemci,&nbsp;Serdar Altınay,&nbsp;Rümeysa İlbar Tartar,&nbsp;Sina Ferahman\",\"doi\":\"10.4274/ejbh.galenos.2022.2022-6-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Phyllodes tumors (PTs) are a rare group of breast tumors. Most malignant transformations are <i>in situ</i> carcinomas that are extremely rare and are limited to individual cases in the literature. The presence of <i>in situ</i>/invasive carcinomas is important as this may alter clinical judgment and management. In this study, we aimed to determine the association of <i>in situ</i>/invasive carcinomas among PTs.</p><p><strong>Materials and methods: </strong>This retrospectively designed study included cases diagnosed with PTs between 2011 and 2020 in the pathology department of a tertiary level hospital. Tumors were grouped into benign, borderline and malignant, according to stromal overgrowth, stromal atypia, stromal cellularity and mitotic activity. In addition, age, location, type of operation, tumor diameter, and surgical margin information were recorded. <i>in situ</i> and/or invasive carcinoma foci accompanying the PTs were assessed.</p><p><strong>Results: </strong>A total of 29 patients diagnosed with PTs were identified, among whom 14 (48.2%) had benign PTs, 10 (34.4%) had borderline PTs, and 5 (17.2%) had malignant PTs. Of the patients with PTs, 3 (10.3%) had coexistent invasive carcinoma and 1 (3.4%) had carcinoma <i>in situ</i>. In this cohort the incidence of coexistence of PT and carcinoma was 4/29 (13.7%), which is much higher than previously reported (1.1% and 6%). The incidence of carcinoma was 2/5 (40%) in malignant PT patients and 2/10 (20%) in borderline PT patients. The coexistence of malignant PTs and carcinoma was significantly higher than those of benign and borderline PTs (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>The multidisciplinary team dealing with breast diseases has a great responsibility in both diagnosis and treatment. We anticipate that these rates will increase with an increase in the awareness and importance of this coexistence of carcinoma and PTs.</p>\",\"PeriodicalId\":11885,\"journal\":{\"name\":\"European journal of breast health\",\"volume\":\"18 4\",\"pages\":\"343-352\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521284/pdf/ejbh-18-343.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of breast health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/ejbh.galenos.2022.2022-6-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of breast health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/ejbh.galenos.2022.2022-6-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:分叶状肿瘤是一类罕见的乳腺肿瘤。大多数恶性转化是原位癌,是极其罕见的,在文献中仅限于个别情况。原位/浸润性癌的存在很重要,因为这可能会改变临床判断和治疗。在这项研究中,我们旨在确定原位/浸润性癌与PTs的关系。材料和方法:本回顾性设计的研究纳入了2011年至2020年在某三级医院病理科诊断为PTs的病例。根据间质增生、间质异型性、间质细胞数量和有丝分裂活性将肿瘤分为良性、交界性和恶性。此外,记录年龄、位置、手术类型、肿瘤直径、手术切缘等信息。评估伴PTs的原位癌灶和/或浸润性癌灶。结果:共确诊29例PTs,其中良性PTs 14例(48.2%),边缘性PTs 10例(34.4%),恶性PTs 5例(17.2%)。其中3例(10.3%)合并浸润性癌,1例(3.4%)合并原位癌。在该队列中,PT和癌共存的发生率为4/29(13.7%),远高于之前报道的(1.1%和6%)。恶性PT患者的癌发生率为2/5(40%),交界性PT患者的癌发生率为2/10(20%)。恶性PTs与癌的共存率明显高于良性和交界性PTs (p)结论:乳腺疾病的多学科团队在诊断和治疗中都负有重大责任。我们预计,随着人们对癌症和PTs共存的认识和重要性的提高,这些比率将会增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Unexpectedly High Coexistence Rate of In Situ/Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study.

Objective: Phyllodes tumors (PTs) are a rare group of breast tumors. Most malignant transformations are in situ carcinomas that are extremely rare and are limited to individual cases in the literature. The presence of in situ/invasive carcinomas is important as this may alter clinical judgment and management. In this study, we aimed to determine the association of in situ/invasive carcinomas among PTs.

Materials and methods: This retrospectively designed study included cases diagnosed with PTs between 2011 and 2020 in the pathology department of a tertiary level hospital. Tumors were grouped into benign, borderline and malignant, according to stromal overgrowth, stromal atypia, stromal cellularity and mitotic activity. In addition, age, location, type of operation, tumor diameter, and surgical margin information were recorded. in situ and/or invasive carcinoma foci accompanying the PTs were assessed.

Results: A total of 29 patients diagnosed with PTs were identified, among whom 14 (48.2%) had benign PTs, 10 (34.4%) had borderline PTs, and 5 (17.2%) had malignant PTs. Of the patients with PTs, 3 (10.3%) had coexistent invasive carcinoma and 1 (3.4%) had carcinoma in situ. In this cohort the incidence of coexistence of PT and carcinoma was 4/29 (13.7%), which is much higher than previously reported (1.1% and 6%). The incidence of carcinoma was 2/5 (40%) in malignant PT patients and 2/10 (20%) in borderline PT patients. The coexistence of malignant PTs and carcinoma was significantly higher than those of benign and borderline PTs (p<0.05).

Conclusion: The multidisciplinary team dealing with breast diseases has a great responsibility in both diagnosis and treatment. We anticipate that these rates will increase with an increase in the awareness and importance of this coexistence of carcinoma and PTs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信